Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
2.160
-0.050 (-2.26%)
At close: Oct 31, 2024, 4:00 PM
2.190
+0.030 (1.39%)
After-hours: Oct 31, 2024, 6:51 PM EDT
Ventyx Biosciences Market Cap
Ventyx Biosciences has a market cap or net worth of $152.65 million as of October 31, 2024. Its market cap has decreased by -85.18% in one year.
Market Cap
152.65M
Enterprise Value
-112.26M
1-Year Change
-85.18%
Ranking
Category
Stock Price
$2.16
Market Cap Chart
Since the IPO on October 21, 2021, Ventyx Biosciences's market cap has decreased from $782.89M to $152.65M, a decrease of -80.50%. That is a compound annual growth rate of -41.73%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 30, 2024 | 156.20M | 7.13% |
Dec 29, 2023 | 145.80M | -92.15% |
Dec 30, 2022 | 1.86B | 85.91% |
Dec 31, 2021 | 998.90M | 27.59% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Actuate Therapeutics | 174.61M |
Acumen Pharmaceuticals | 174.53M |
Caribou Biosciences | 174.40M |
Checkpoint Therapeutics | 172.87M |
The Joint | 170.06M |
Context Therapeutics | 168.00M |
Stereotaxis | 167.97M |
Lineage Cell Therapeutics | 166.18M |